RDNT (RadNet) Net Issuance of Preferred Stock : $0 Mil (TTM As of Mar. 2025)

View and export this data going back to 1997. Start your Free Trial

What is RadNet Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

RadNet's net issuance of preferred for the three months ended in Mar. 2025 was $0 Mil. The number is 0, which means that RadNet has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

RadNet's net issuance of preferred for the trailing twelve months (TTM) ended in Mar. 2025 was $0 Mil.

RadNet Net Issuance of Preferred Stock Historical Data

The historical data trend for RadNet's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RadNet Net Issuance of Preferred Stock Chart

RadNet Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

RadNet Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Issuance of Preferred Stock	Get a 7-Day Free Trial															-	-	-	-	-

RadNet Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

RadNet Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of RadNet's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

RadNet Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » RadNet Inc (NAS:RDNT) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

PQIA:Germany

Address

1510 Cotner Avenue, Los Angeles, CA, USA, 90025

Website

http://www.radnet.com

RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.

Executives

Norman R Hames	director, officer: Vice President
David L Swartz	director	1510 COTNER AVENUE, LOS ANGELES CA 90025
David Jeffrey Katz	officer: EVP and General Counsel	1510 COTNER AVE, LOS ANGELES CA 90025
Ranjan Jayanathan	officer: Chief Information Officer	13388 HUNT RIDGE ROAD, ELLICOTT CITY MD 21042
Michael N Murdock	officer: Executive Vice President	3600 JP MORGAN CHASE TOWER, 2200 ROSS AVENUE, DALLAS TX 752012776
Mital Patel	officer: Executive Vice President	1510 COTNER AVENUE, LOS ANGELES CA 90025
Gregory E. Spurlock	director	4116 E. NORTHRIDGE CIRCLE, MESA AZ 85215-9807
Lawrence L Levitt	director	2934 1/2 BEVERLY GLEN CIRCLE #325, LOS ANGELES CA 90077
Stephen M Forthuber	officer: Executive Vice President	3600 JP MORGAN CHASE TOWER, 2200 ROSS AVENUE, DALLAS TX 75201-2776
Gregory Sorensen	director, officer: EVP Chief Science Officer	C/O DFB HEALTHCARE ACQUISITIONS CORP, 780 THIRD AVENUE, NEW YORK NY 10017
Mark Stolper	director	150 COTNER AVENUE, LOS ANGELES CA 90025
Christine Nayoma Gordon	director	3081 PANAMA AVE., CARMICHAEL CA 95608
Ruth Louisa Villigerwilson	director, officer: Senior Vice President	3700 WALNUT AVENUE, LONG BEACH CA 90801
John V Crues	director	1510 COTNER AVE, LOS ANGELES CA 90025
Laura Pastre Jacobs	director	10154 BRIDLEVALE DRIVE, LOS ANGELES CA 90064